These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2113 related items for PubMed ID: 2111373

  • 1. Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing.
    Wiebke EA, Custer MC, Rosenberg SA, Lotze MT.
    J Biol Response Mod; 1990 Apr; 9(2):113-26. PubMed ID: 2111373
    [Abstract] [Full Text] [Related]

  • 2. Dual effects of cytokines in regulation of MHC-unrestricted cell mediated cytotoxicity.
    Reiter Z.
    Crit Rev Immunol; 1993 Apr; 13(1):1-34. PubMed ID: 8466640
    [Abstract] [Full Text] [Related]

  • 3. Activated endothelial cells resist lymphokine-activated killer cell-mediated injury. Possible role of induced cytokines in limiting capillary leak during IL-2 therapy.
    Mier JW, Brandon EP, Libby P, Janicka MW, Aronson FR.
    J Immunol; 1989 Oct 01; 143(7):2407-14. PubMed ID: 2528594
    [Abstract] [Full Text] [Related]

  • 4. The effect of anti-CD3 on the induction of non-MHC restricted cytolytic activity.
    Watanabe H, Narumi K, Stewart CC, Arbuck SG, Foon KA, Goldrosen MH.
    Anticancer Res; 1992 Oct 01; 12(6B):1925-33. PubMed ID: 1295440
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Retaliation against tumor cells showing aberrant HLA expression using lymphokine activated killer-derived T cells.
    Falk CS, Noessner E, Weiss EH, Schendel DJ.
    Cancer Res; 2002 Jan 15; 62(2):480-7. PubMed ID: 11809699
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Relation of natural killer cell line NK-92-mediated cytolysis (NK-92-lysis) with the surface markers of major histocompatibility complex class I antigens, adhesion molecules, and Fas of target cells.
    Komatsu F, Kajiwara M.
    Oncol Res; 1998 Jan 15; 10(10):483-9. PubMed ID: 10338151
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Lytic susceptibility of target cells to cytotoxic T cells is determined by their constitutive major histocompatibility complex class I antigen expression and cytokine-induced activation status.
    Ritter M, Huber C, Auböck J, Pohl-Markl H, Troppmair J, Herold M, Gächter A, Nussbaumer W, Böck G, Nachbaur D.
    Immunology; 1994 Apr 15; 81(4):569-77. PubMed ID: 7913694
    [Abstract] [Full Text] [Related]

  • 11. Characteristics and mechanism of IFN-gamma-induced protection of human tumor cells from lysis by lymphokine-activated killer cells.
    de Fries RU, Golub SH.
    J Immunol; 1988 May 15; 140(10):3686-93. PubMed ID: 3129500
    [Abstract] [Full Text] [Related]

  • 12. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
    Lowdell MW, Shamim F, Hamon M, Macdonald ID, Prentice HG.
    Exp Hematol; 1995 Dec 15; 23(14):1530-4. PubMed ID: 8542943
    [Abstract] [Full Text] [Related]

  • 13. Tumor targets stimulate IL-2 activated killer cells to produce interferon-gamma and tumor necrosis factor.
    Chong AS, Scuderi P, Grimes WJ, Hersh EM.
    J Immunol; 1989 Mar 15; 142(6):2133-9. PubMed ID: 2493506
    [Abstract] [Full Text] [Related]

  • 14. Induction of human lymphokine-activated killer cells by IFN-alpha and IFN-gamma.
    Ellis TM, McKenzie RS, Simms PE, Helfrich BA, Fisher RI.
    J Immunol; 1989 Dec 15; 143(12):4282-6. PubMed ID: 2512355
    [Abstract] [Full Text] [Related]

  • 15. Cytokines alter target cell susceptibility to lysis. II. Evaluation of tumor infiltrating lymphocytes.
    Stötter H, Wiebke EA, Tomita S, Belldegrun A, Topalian S, Rosenberg SA, Lotze MT.
    J Immunol; 1989 Mar 01; 142(5):1767-73. PubMed ID: 2493053
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Enhancement of human natural killer cell function by the combined effects of tumor necrosis factor alpha or interleukin-1 and interferon-alpha or interleukin-2.
    Ostensen ME, Thiele DL, Lipsky PE.
    J Biol Response Mod; 1989 Feb 01; 8(1):53-61. PubMed ID: 2493514
    [Abstract] [Full Text] [Related]

  • 18. H-2 antigen expression and sensitivity of BL6 melanoma cells to natural killer cell cytotoxicity.
    Gorelik E, Gunji Y, Herberman RB.
    J Immunol; 1988 Mar 15; 140(6):2096-102. PubMed ID: 3126240
    [Abstract] [Full Text] [Related]

  • 19. IL-4 inhibits IL-2 induction of LAK cytotoxicity in lymphocytes from a variety of lymphoid tissues.
    Colquhoun SD, Economou JS, Shau H, Golub SH.
    J Surg Res; 1993 Nov 15; 55(5):486-92. PubMed ID: 8231167
    [Abstract] [Full Text] [Related]

  • 20. Protection of cultured human monocytes from lymphokine-activated killer-mediated lysis by IFN-gamma.
    Blanchard DK, Djeu JY.
    J Immunol; 1988 Dec 01; 141(11):4067-73. PubMed ID: 2460557
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 106.